1. Home
  2. RFL vs FSEA Comparison

RFL vs FSEA Comparison

Compare RFL & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • FSEA
  • Stock Information
  • Founded
  • RFL 2017
  • FSEA 1890
  • Country
  • RFL United States
  • FSEA United States
  • Employees
  • RFL N/A
  • FSEA N/A
  • Industry
  • RFL Real Estate
  • FSEA Savings Institutions
  • Sector
  • RFL Finance
  • FSEA Finance
  • Exchange
  • RFL Nasdaq
  • FSEA Nasdaq
  • Market Cap
  • RFL 55.3M
  • FSEA 43.6M
  • IPO Year
  • RFL N/A
  • FSEA N/A
  • Fundamental
  • Price
  • RFL $1.92
  • FSEA $9.94
  • Analyst Decision
  • RFL
  • FSEA
  • Analyst Count
  • RFL 0
  • FSEA 0
  • Target Price
  • RFL N/A
  • FSEA N/A
  • AVG Volume (30 Days)
  • RFL 27.8K
  • FSEA 11.1K
  • Earning Date
  • RFL 12-27-2024
  • FSEA 11-08-2024
  • Dividend Yield
  • RFL N/A
  • FSEA N/A
  • EPS Growth
  • RFL N/A
  • FSEA N/A
  • EPS
  • RFL N/A
  • FSEA N/A
  • Revenue
  • RFL $697,000.00
  • FSEA $11,390,000.00
  • Revenue This Year
  • RFL N/A
  • FSEA N/A
  • Revenue Next Year
  • RFL N/A
  • FSEA N/A
  • P/E Ratio
  • RFL N/A
  • FSEA N/A
  • Revenue Growth
  • RFL 151.62
  • FSEA N/A
  • 52 Week Low
  • RFL $1.29
  • FSEA $7.25
  • 52 Week High
  • RFL $2.50
  • FSEA $10.38
  • Technical
  • Relative Strength Index (RSI)
  • RFL 53.58
  • FSEA 66.63
  • Support Level
  • RFL $1.71
  • FSEA $9.92
  • Resistance Level
  • RFL $1.92
  • FSEA $10.32
  • Average True Range (ATR)
  • RFL 0.10
  • FSEA 0.27
  • MACD
  • RFL -0.00
  • FSEA 0.07
  • Stochastic Oscillator
  • RFL 84.00
  • FSEA 66.15

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About FSEA First Seacoast Bancorp Inc.

First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.

Share on Social Networks: